Skip to main content
Plastic Surgery logoLink to Plastic Surgery
. 2020 Jun 4;28(4):215–221. doi: 10.1177/2292550320928557

Management of Primary Necrotizing Fasciitis of the Breast: A Systematic Review

La prise en charge de la fasciite nécrosante primaire du sein : une analyse systématique

Ryan D Konik 1,, Gregory S Huang 1
PMCID: PMC7644830  PMID: 33215036

Abstract

Purpose:

Necrotizing fasciitis (NF) is a life-threatening infection that involves spreading necrosis of the subcutaneous tissue and fascia that affects the extremities, abdominal wall, and perineum. Primary infection of the breast is a rare occurrence. Shah et al described the first case of primary breast NF and recommended radical “pseudotumor” excision and delayed skin closure months after resolution. Numerous other cases reported were successfully managed with different strategies. We aimed to summarize management options for primary breast NF through a systematic review of the literature.

Methods:

A systematic review of English literature was performed using PubMed. A total of 58 abstracts were reviewed. Data were abstracted from 25 cases that met inclusion criteria.

Results:

A total of 25 cases of primary NF of the breast without an inciting event were found within the literature. Common initial operations included total mastectomy (36.0%), excisional debridement (32.0%), and partial mastectomy (12.0%). A total or radical mastectomy was completed for definitive source control in 13 (52.0%) cases. A total of 18 cases underwent reconstruction. Split-thickness skin grafts (44.4%) and delayed primary closures (33.3%) were the most common methods of reconstruction.

Conclusion:

Majority of cases with primary breast NF are managed with a total mastectomy to gain source control. Reconstruction using split-thickness skin grafts was most common. Other options included delayed primary closure, full thickness skin grafts, local tissue rearrangement, and pedicle flap reconstruction. Reconstruction should be patient dependent, but the whole arsenal of the reconstructive ladder may be used.

Keywords: necrotizing fasciitis, breast, necrotizing soft tissue infection, management

Introduction

Necrotizing fasciitis (NF) is a life-threatening infection involving rapidly spreading necrosis of the subcutaneous tissue and fascia. Patients often present in septic shock with multi-organ failure. Clinical examination findings may demonstrate erythema, swelling, pain disproportionate to examination, necrosis, blisters, bullae, and crepitus. Common locations for NF include the extremities, abdominal wall, and perineum.1 Comorbidities associated with NF include diabetes mellitus, peripheral vascular disease, alcoholic liver disease, immunosuppression, and obesity.2,3 An inciting event, such as a traumatic injury, insect bite, injection site, or procedural site, is identified as the cause of the infection in the majority of cases.4 The breasts are a rare location for such an infection, with most cases presenting after trauma or surgical intervention. Primary NF of the breast is often misdiagnosed as an abscess or cellulitis leading to treatment delays.5 Prompt assessment and treatment are pivotal for successful patient outcomes.

The management of NF involves fluid resuscitation, broad-spectrum antibiotics, and prompt surgical intervention. Shah et al described the first case of primary NF of the breast in a 50-year-old diabetic female. A 6-point management plan was recommended from his observations and included radical “pseudotumor” excision, reexploration of the wound within 24 hours, and delayed skin closure several months after complete recovery.6 Since that report, there have been numerous reported cases of primary NF of the breast with management strategies deviating from the initially proposed recommendations. Several questions arise from these new observed strategies such as whether a total mastectomy is required for definitive source control, if the timing to reconstruction must be several months after source control, and if there are other successful reconstruction methods other than delayed primary closure. Primary NF of the breast presents a unique clinical scenario. There is no review in the literature summarizing these management strategies. The objective of this study was to summarize potential management strategies, including source control operations and reconstruction methods through a systematic review of the literature.

Methods

A systematic review of English literature was performed using PubMed without temporal limitations. A search strategy using the phrases “primary necrotizing fasciitis” or “breast necrotizing fasciitis” or “breast necrotizing soft tissue infection” or “breast gangrene” was used to obtain relevant abstracts. This search strategy obtained a total of 409 articles, which was narrowed down to 52 relevant articles after reviewing the titles. An additional 6 articles were obtained from cross examination of references from selected titles. A total of 58 articles were selected for potential abstract review by the authors. From that cohort, a total of 19 articles were excluded from this selection secondary to no available abstract (n = 12), non-English language (n = 5), and description of a non-necrotizing infection (n = 2). The remaining 39 articles were assessed for qualitative analysis eligibility. Inclusion criteria for qualitative analysis included NF localized to the breast and primary infection without an inciting event, such as an underlying cancer or prior procedure. A total of 13 articles were excluded based on inclusion criteria.7-19 A single case series was excluded because of inadequate data.20 Therefore, a total of 25 articles were included in the qualitative analysis. The majority of these articles were single case reports of primary necrotizing infections. Data abstracted included age, comorbidities, mortality, time to presentation, initial source control operation, time to second-look operation, definitive source control operation, microbiology cultures, reconstruction, and time to reconstruction. Statistical analysis was accomplished using Microsoft Excel 2011. A PRISMA flowchart of the literature search is provided in Figure 1.

Figure 1.

Figure 1.

PRISMA flow chart of literature search.

Results

A total of 25 cases of primary NF of the breast without an inciting event were found in the literature. Information on articles included in the qualitative analysis is provided in Table 1. There were 2 cases of mortality (2/25) with a mortality rate of 8.0%. The average age among the study population was 46.2 ± 16.0 years. Demographics and significant comorbidities are included in Table 2. Average time to initial presentation was 6.6 ± 4.3 days. Initial source control operations included total mastectomy (36.0%, 9/25), excisional debridement (32.0%, 8/25), partial mastectomy (12.0%, 3/25), debridement with sparing of the nipple areolar complex (8.0%, 2/25), incision and drainage (4.0%, 1/25), radical mastectomy (4.0%, 1/25), and bilateral radical mastectomy (4.0%, 1/25), as shown in Table 3. Average time to a second look operation was 3.3 ± 3.4 days. Several cases reported multiple operations to obtain source control. These data were summarized into a definitive source control subcategory shown in Table 3. Three definitive source control categories were established identified as all mastectomies (modified and radial mastectomies), all debridements (nipple areolar complex sparing and nonsparing), and partial mastectomy. The majority of patients required a mastectomy for definitive source control 52.0% (13/25), whereas 32.0% (8/25) of patients were managed with serial debridements and 16.0% (4/25) underwent partial mastectomies. The analysis of microbiology cultures revealed that 40.0% (10/25) of infections were caused by polymicrobial flora and 20.0% (5/25) of infections secondary to Streptococcus pyogenes. Other infectious agents included Streptococcus milleri, Serratia marcescens, Streptococcus sanguis, Escherichia coli, Pseudomonas aeruginosa, Corynebacterium striatum, and Clostiridum septicum.

Table 1.

Case Studies Included in the Systematic Review.

References Year Initial operation Additional operation Reconstruction Outcome
Shah et al6 2001 Right mastectomy Delayed primary closure Survived
Nizami et al21 2006 Right debridement Right mastectomy Split-thickness skin graft Survived
Rajakannu et al22 2006 Right mastectomy Split-thickness skin graft Survived
Wong et al23 2008 Right partial mastectomy Delayed primary closure Survived
Hanif et al24 2008 Left mastectomy Left debridement Survived
Delotte et al25 2008 Right mastectomy Survived
Keune et al26 2009 Left debridement Left mastectomy Survived
Venkatramani et al27 2009 Left mastectomy Survived
Vishwanath et al28 2011 Right mastectomy Right debridement Split-thickness skin graft Survived
Soliman et al29 2011 Right I&D Right NAC-sparing debridement Split-thickness skin graft Survived
Parker et al30 2011 Right partial mastectomy Right debridement Survived
Kaczynski et al1 2012 Right debridement Right partial mastectomy Delayed primary closure Survived
Adachi et al31 2012 Right debridement Radical mastectomy Split-thickness skin graft Survived
Ablett et al32 2012 Left mastectomy Left debridement Delayed primary closure Survived
Rehman et al33 2012 Bilateral radical mastectomy Deceased
Pote et al34 2013 Right debridement Split-thickness skin graft Survived
Yaji et al35 2014 Left mastectomy Deceased
Mufty et al36 2014 Left debridement Left debridement Delayed primary closure Survived
Yang et al37 2015 Left NAC-sparing debridement Left debridement Split-thickness skin graft Survived
Lee et al38 2015 Left NAC-sparing debridement Left debridement Negative-pressure vac Survived
Lee et al5 2016 Right debridement Right debridement Latissimus dorsi flap Survived
Marongiu et al39 2016 Right debridement Right debridement Full-thickness skin graft Survived
Ward et al40 2016 Left radical mastectomy Left debridement Delayed primary closure Survived
Fayman et al41 2017 Right mastectomy Right debridement Split-thickness skin graft Survived
Konik et al42 2017 Left partial mastectomy Local tissue rearrangement Survived

Table 2.

Demographics of Study Population.

Comorbidities Totals (n = 25) %
Hypertension 7 28
Diabetes mellitus 6 24
Obesity 4 16
Immunocompromised 3 16
COPD 1 4
Asthma 1 4
Smoker 1 12

Table 3.

Initial Source Control Operation and Definitive Source Control Operation.

Totals (N = 25) %
Initial source control operation
 Total mastectomy 9 36.0
 Debridement 8 32.0
 Partial mastectomy 3 12.0
 Debridement with sparing NAC 2 8.0
 Incision and drainage 1 4.0
 Radical mastectomy 1 4.0
 Bilateral radical mastectomy 1 4.0
Definitive source control operation
 Mastectomy 13 52.0
 Serial debridement 8 32.0
 Partial mastectomy 4 16.0

Abbreviation: NAC, nipple-areolar complex.

Only 18 cases of the 25 analyzed provided adequate information on reconstruction methods. The average time from definitive source control to reconstruction was 15.6 ± 11.7 days. The various reconstruction methods used are included in Table 4. The majority of patients underwent either split-thickness skin grafting 44.0% (8/18) or delayed primary closure 33.3% (6/18). A subcategory analysis examined reconstruction methods for those groups of patients who underwent a total mastectomy, serial debridements, or partial mastectomy for definitive source control (Table 5). From the mastectomy group, most patients underwent split-thickness skin grafting 30.8% (4/13) or delayed primary closures 23.1% (3/13). The remaining mastectomy cases did not include reconstruction management information. Majority of patients who underwent serial debridements for infection control underwent split-thickness skin grafting (50.0%, 4/8) for reconstruction. In the partial mastectomy group, 50.0% (2/4) underwent delayed primary closure.

Table 4.

Common Reconstruction Methods after Final Source Control Operation.

Reconstruction Totals (N = 18) %
Split-thickness skin graft 8 44.4
Delayed primary closure 6 33.3
Full-thickness skin graft 1 5.6
Local tissue rearrangement 1 5.6
Negative-pressure wound vac 1 5.6
Latissimus dorsi flap 1 5.6

Table 5.

Reconstruction Methods after Mastectomy, Serial Debridement, and Partial Mastectomy.

Totals %
Reconstruction for mastectomy
 Split-thickness skin graft 4 30.8
 Delayed primary closure 3 23.1
 Undetermined 6 46.2
Reconstruction for debridement
 Split-thickness skin graft 4 50
 Delayed primary closure 1 12.5
 Latissimus dorsi flap 1 12.5
 Negative-pressure wound vac 1 12.5
 Full-thickness skin graft 1 12.5
Reconstruction for partial mastectomy
 Delayed primary closure 2 50
 Local tissue rearrangement 1 25
 Undetermined 1 25

Discussion

Necrotizing fasciitis is a life-threatening infection involving the fascia and subcutaneous tissues. Typical clinical examination findings include erythema, swelling, pain disproportionate to examination, necrosis, blisters or bullae formation, and crepitus. Patients may present in septic shock with multi-organ failure. The extremities, trunk, and perineum are commonly affected locations.2 The cause of necrotizing infections are often attributed to a trivial event, such as a traumatic injury, insect bite, or injection.4 Primary NF of the breast without an inciting event, such as a prior operation, is a rare event. The standard of treatment is fluid resuscitation, broad-spectrum antibiotics, and urgent surgical debridement of non-viable tissue. Shah et al described a case of primary NF of the breast and advocated for a 6-point management strategy that included a radical “pseudotumor” excision, reexploration within 24 hours of initial operation, and delayed primary closure several months after the infection had been cleared.

Several comorbidities associated with NF include diabetes mellitus, peripheral vascular disease, alcoholic liver disease, obesity, and immunosuppression.2,3 The comorbidities of the patients within this systematic review are similar to the majority having diabetes mellitus or hypertension. Obesity and immunosuppression were other common comorbidities identified.

Prompt diagnosis is critical for survival and breast salvage. Delays in diagnosis are common, as cutaneous findings may not be readily apparent secondary to the thicker tissue between the deep fascia and skin. When cutaneous signs are evident, the damage is extensive and most likely necessitates a mastectomy. Based on the results of this systematic review, a total mastectomy was required to obtain source control in many of the cases. However, serial debridements and, occasionally, a partial mastectomy were all that was needed for surgical treatment of the infection. This may have been possible secondary to a large amount of subcutaneous tissue and the breast’s robust blood supply. It is pivotal to remove all necrotic tissue during excisional debridement in order to obtain complete infection control. Therefore, we recommend complete resection of necrotic tissue while being cognizant of preserving as much healthy breast tissue as possible. Still, it is imperative that a second look of the operative area be performed within 24 to 48 hours after the initial debridement in order to obtain adequate source control.

There are 2 types of NF infections according to microbiology cultures. Type I infections are the result of polymicrobial infections by both aerobic and anaerobic organisms. Type II infections are caused by monomicrobial organism such as S pyogenes. Polymicrobial organism were found to be the most common cause of infections in this review. Streptococcus pyogenes was found to be the second most common.

In terms of reconstruction, split-thickness skin grafts were the primary reconstruction method used in the majority of cases. Reconstruction options are largely dependent upon the final amount of breast tissue available and the area of resection. Other options include delayed primary closure, full-thickness skin grafts, local tissue rearrangement, and pedicle flap reconstruction. The whole arsenal of the reconstructive ladder may be employed. Reconstruction can occur once the infection has cleared, and the patient is stable enough for another operation. There is no benefit to waiting several weeks until proceeding with reconstruction, evidenced by the average time to reconstruction of about 2 weeks.

Shah et al described the first case of primary NF of the breast in a 50-year-old diabetic female. A 6-point management plan was established for the treatment of such an infection from his observations. The plan advocated for a radical “pseudotumor” excision, reexploration of the site within 24 to 48 hours, and delayed primary skin closure several months after recovery.6 It is apparent that many cases of breast NF result in a total mastectomy from this systemic review. However, this type of infection may be managed by serial debridements or a partial mastectomy. Regardless, the removal of all necrotic tissue is imperative in order to eradicate the infection. The wound should be re-explored within 24 to 48 hours either in the operating room or at bedside, depending upon the patient’s clinical status. Reconstruction of the defect may be completed once the infection has been controlled, and the patient’s clinical status permits. This usually occurred within 2 weeks of the final source control operation. Split-thickness skin grafting was the main method of reconstruction, instead of delayed primary closure.

A limitation of this study is that it contains a limited number of case reports, therefore making inferences from these data difficult. Despite the lack of cases, this systematic review does provide an adequate reference for treatment and reconstructive options when dealing with NF of the breast.

Based on this systematic review, we propose several management strategies for the treatment of primary NF of the breast. First, a prompt diagnosis is critical to patient’s overall outcome. The patient should be resuscitated with crystalloid fluids and broad-spectrum antibiotics administered. Operative source control intervention should be completed as soon as a diagnosis is established. Debridement of necrotic tissue should be completed until healthy, viable tissue is encountered, which may necessitate a complete mastectomy. Reexploration of the wound should be completed in 24 to 48 hours to ensure the removal of all necrotic tissue. There are a wide variety of reconstruction options with split-thickness skin grafts being a common choice. Reconstruction of the defect can be completed within 2 weeks or once the patient is stable and free of infection.

Footnotes

Level of Evidence: Level 3, Therapeutic

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD: Ryan D. Konik, MD Inline graphic https://orcid.org/0000-0002-6433-8524

References

  • 1. Kaczynski J, Dillon M, Hilton J. Breast necrotising fasciitis managed by partial mastectomy. BMJ Case Rep. 2012;2012:bcr0220125816 doi:10.1136/bcr.02.2012.5816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–710. [DOI] [PubMed] [Google Scholar]
  • 3. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A(8):14–60. [PubMed] [Google Scholar]
  • 4. Edlich RF, Cross CL, Dahlstrom J, Long WB. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010;39(2):261–265. [DOI] [PubMed] [Google Scholar]
  • 5. Lee JH, Lim YS, Kim NG, Lee KS, Kim JS. Primary necrotizing fasciitis of the breast in an untreated patient with diabetes. Arch Plast Surg. 2016;43:613–614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Shah J, Sharma AK, O’Donoghue JM, Mearns B, Johri A, Thomas V. Necrotising fasciitis of the breast. Br J Plast Surg. 2001;54(1):67–68. [DOI] [PubMed] [Google Scholar]
  • 7. Subramanian A, Thomas G, Lawn A, Jackson P, Layer G. Necrotising soft tissue infection following mastectomy. J Surg Case Rep. 2010;2010(1):4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. AL Shareef B, AL Saleh N. Necrotizing fasciitis of the breast: case report with literature review. Case Rep Surg. 2018;2018(4):1370680 doi:10.1155/2018/1370680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Pek CH, Lim J, Ng HW, et al. Extensive necrotizing fasciitis after fat grafting for bilateral breast augmentation: recommended approach and management. Arch Plast Surg. 2015;42(3):365–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Angarita FA, Acuna SA, Torregrosa L, et al. Bilateral necrotizing fasciitis of the breast following quadrantectomy. Breast Cancer. 2014;21(1):108–114. doi:10.1007/s12282-010-0219-4 [DOI] [PubMed] [Google Scholar]
  • 11. Yusuf E, Steinrücken J, Nordback S, Trampuz A. Necrotizing fasciitis after breast augmentation: rapid microbiologic detection by using sonication of removed implants and microcalorimetry. Am J Clin Pathol. 2014;142(2):269–272. [DOI] [PubMed] [Google Scholar]
  • 12. Costa Vieira RDA, Zucca Mathes AG, Michelli RA, et al. Necrotizing soft tissue infection of the breast: case report and literature review. Surg Infect (Larchmt). 2012;13(4):270–275. doi:10.1089/sur.2011.029 [DOI] [PubMed] [Google Scholar]
  • 13. Flandrin A, Rouleau C, Azar CC, Dubon O, Giacalone PL. First report of a necrotising fasciitis of the breast following a core needle biopsy. Breast J. 2009;15(2):199–201. [DOI] [PubMed] [Google Scholar]
  • 14. Velchuru VR, Van Der Walt M, Sturzaker HG. Necrotizing fasciitis in a postmastectomy wound. Breast J. 2006;12(1):72–74. [DOI] [PubMed] [Google Scholar]
  • 15. Sharma D, Dalencourt G, Bitterly T, Benotti PN. Small intestinal perforation and necrotizing fasciitis after abdominal liposuction. Aesthetic Plast Surg. 2006;30(6):712–716. [DOI] [PubMed] [Google Scholar]
  • 16. Smith C, Goslin B. Clostridium sordellii surgical site infection after breast mass excision: case report. Surg Infect (Larchmt). 2013;14(1):160–162. doi:10.1089/sur.2011.060 [DOI] [PubMed] [Google Scholar]
  • 17. Gehlen JM, Luyer MD, Keymeulen K, Greve JW. Necrotizing fasciitis following modified radical mastectomy. Breast J. 2008;14(2):199–200. doi:10.1111/j.1524-4741.2007.00556.x [DOI] [PubMed] [Google Scholar]
  • 18. Agrawal S, Jayant K, Agarwal R. Breast gangrene: a rare source of severe sepsis. BMJ Case Rep. 2014;2014:bcr2013203467 doi:10.1136/bcr-2013-203467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Salhab M, Al Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol. 2005;2(1):26 doi:10.1186/1477-7800-2-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Wani I, Bakshi I, Parray FQ, et al. Breast gangrene. World J Emerg Surg. 2011;6(2):29 doi:10.1186/1749-7922-6-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Nizami S, Mohiuddin K, Mohsin AE, Zafar H, Memon MA. Necrotizing fasciitis of the breast. Breast J. 2006;12(2):168–169. [DOI] [PubMed] [Google Scholar]
  • 22. Rajakannu M, Kate V, Ananthakrishnan N. Necrotizing infection of the breast mimicking carcinoma. Breast J. 2006;12(3):266–267. [DOI] [PubMed] [Google Scholar]
  • 23. Wong CH, Tan BK. Necrotizing fasciitis of the breast. Plastic Reconstr Surg. 2008;122:151e–152e. [DOI] [PubMed] [Google Scholar]
  • 24. Hanif MA, Bradley MJ. Sonographic findings of necrotizing fasciitis in the breast. J Clin Ultrasound. 2008;36(8):517–519. [DOI] [PubMed] [Google Scholar]
  • 25. Delotte J, Karimdjee BS, Cua E, Pop D, Bernard JL, Bongain A, Benchimol D. Gas gangrene of the breast: management of a potential life-threatening infection. Arch Gynecol Obstet. 2009;279(1):79–81. [DOI] [PubMed] [Google Scholar]
  • 26. Keune JD, Melby S, Kirby JP, Aft RL. Shared management of a rare necrotizing soft tissue infection of the breast. Breast J. 2009;15(3):321–323. [DOI] [PubMed] [Google Scholar]
  • 27. Venkatramani V, Pillai S, Marathe S, Rege SA, Hardikar JV. Breast gangrene in an HIV-positive patient. Ann R Coll Surg Engl. 2009;91(5):W13–W14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Vishwanath G, Basarkod SI, Katageri GM, Mirji P, Mallapur AS. Necrotising fasciitis of the breast with shock and postpartum psychosis. J Clin Diagn Res. 2011;5:1117–1119. [Google Scholar]
  • 29. Soliman MO, Ayyash EH, Aldahham A, Asfar S. Necrotizing fasciitis of the breast: a case managed without mastectomy. Med Princ Pract. 2011;20(6):567–569. doi:10.1159/000330026 [DOI] [PubMed] [Google Scholar]
  • 30. Parker J, Sabanathan S. Synergistic gangrene of the breast in a patient with type 2 diabetes. JRSM Short Rep. 2011;2(9):74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Adachi K, Tsutsumi R, Yoshida Y, Watanabe T, Nakayama B, Yamamoto O. Necrotizing fasciitis of the breast and axillary regions. Eur J Dermatol. 2012;22(6):817–818. [DOI] [PubMed] [Google Scholar]
  • 32. Ablett DJ, Bakker-Dyos J, Rainey JB. Primary necrotizing fasciitis of the breast: a case report and review of the literature. Scott Med J. 2012;57(1):60. [DOI] [PubMed] [Google Scholar]
  • 33. Rehman T, Moore TA, Seoane L. Serratia marcescens necrotizing fasciitis presenting as bilateral breast necrosis. J Clin Microbiol. 2012;50(10):3406–3408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Pote MP, Kelkar VP, Bhople L, Patil A. Necrotizing fasciitis of the breast: a rare presentation in post-partum mother. IOSR-JDMS. 2013;11(5):16–18. [Google Scholar]
  • 35. Yaji P, Bhat B. Primary necrotising fasciitis of the breast: case report and brief review of literature. J Clin Diagn Res. 2014;8(7):ND01–NDO2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Mufty H, Smeets A, Christiaens MR. An atypical case of necrotizing fasciitis of the breast. Acta Chir Belg. 2014;114(3):215–218. [DOI] [PubMed] [Google Scholar]
  • 37. Yang B, Connolly S, Ball W. Necrotising fasciitis of the breast: a rare primary case with conservation of the nipple and literature review. JPRAS Open. 2015;6(3):15–19. [Google Scholar]
  • 38. Lee J, Lee KJ, Sun WY. Necrotizing fasciitis of the breast in a pregnant woman successfully treated using negative-pressure wound therapy. Ann Surg Treat Res. 2015;89(2):102–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Marongiu F, Buggi F, Mingozzi M, Curcio A, Folli S. A rare case of primary necrotising fasciitis of the breast: combined use of hyperbaric oxygen and negative pressure wound therapy to conserve the breast. Review of literature. Int Wound J. 2017;14(2):349–354. doi:10.1111/iwj.12607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Ward ND, Harris JW, Sloan DA. Necrotizing fasciitis of the breast requiring emergent radical mastectomy. Breast J. 2017;23(1):95–99. doi:10.1111/tbj.12686 [DOI] [PubMed] [Google Scholar]
  • 41. Fayman K, Wang K, Curran R. A case report of primary necrotising fasciitis of the breast: a rare but deadly entity requiring rapid surgical management. Int J Surg Case Rep. 2017;31:221–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Konik RD, Cash AD, Huang GS. Necrotizing fasciitis of the breast managed by partial mastectomy and local tissue rearrangement. Case Reports Plast Surg Hand Surg. 2017;4(1):77–80. doi:10.1080/23320885.2017.1364970 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Plastic Surgery are provided here courtesy of SAGE Publications

RESOURCES